|

货币单位:美元(USD)

Argos Therapeutics, Inc. (args)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Hubert Birner	Currently, Jeffrey D. Abbey holds the position of President, Chief Executive Officer & Director at Argos Therapeutics, Inc. He is also on the board of North Carolina Biosciences Organization. He previously was Vice President-Finance & Business Development at Internet Appliance Network and Partner at Eilenberg & Krause LLP. Mr. Abbey received an undergraduate degree from Brown University and a graduate degree and an MBA from the University of Virginia.
Robert F. Carey	Robert F. Carey is Chief Business Officer & Executive Vice President at Horizon Pharma Plc and Chief Business Officer & Executive Vice President at Hyperion Therapeutics, Inc. and on the board of 5 other companies. In his past career he was Managing Director at Dresdner Kleinwort Wasserstein, Managing Director at Vector Securities International, Inc., Principal at Shearson Lehman Hutton, Inc., Principal at Ernst & Whinney, Chief Business Officer & Executive Vice President at Horizon Pharma, Inc. and Managing Director at JMP Securities LLC. He received an undergraduate degree from the University of Notre Dame.

Hubert Birner

Currently, Jeffrey D. Abbey holds the position of President, Chief Executive Officer & Director at Argos Therapeutics, Inc. He is also on the board of North Carolina Biosciences Organization. He previously was Vice President-Finance & Business Development at Internet Appliance Network and Partner at Eilenberg & Krause LLP. Mr. Abbey received an undergraduate degree from Brown University and a graduate degree and an MBA from the University of Virginia.

Robert F. Carey

Robert F. Carey is Chief Business Officer & Executive Vice President at Horizon Pharma Plc and Chief Business Officer & Executive Vice President at Hyperion Therapeutics, Inc. and on the board of 5 other companies. In his past career he was Managing Director at Dresdner Kleinwort Wasserstein, Managing Director at Vector Securities International, Inc., Principal at Shearson Lehman Hutton, Inc., Principal at Ernst & Whinney, Chief Business Officer & Executive Vice President at Horizon Pharma, Inc. and Managing Director at JMP Securities LLC. He received an undergraduate degree from the University of Notre Dame.